Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9P3M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,627
Award facts
- Contract value 100% obligated
- $63,626.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $63,626.53 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen injections on November 24, 2025, with completion expected by November 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat various inflammatory and autoimmune conditions, representing a specialized pharmaceutical procurement supporting military and federal healthcare requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that serves as the company's primary vehicle for supplying pharmaceuticals and medical commodities to the Defense Health Agency and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive contract portfolio with DLA for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The competitively awarded contract reflects the contractor's capability to fulfill federal procurement requirements for critical pharmaceutical support to military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F9P3M?
SPE2DR26F9P3M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F9P3M worth?
The government has obligated $63,627 on SPE2DR26F9P3M.
Is contract SPE2DR26F9P3M an order under another contract?
Yes. SPE2DR26F9P3M is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P3M competed?
The extent of competition for SPE2DR26F9P3M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award